376 related articles for article (PubMed ID: 18086120)
1. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
Nishida T; Kobashi H; Fujioka S; Fujio K; Takaguchi K; Ikeda H; Kawaguchi M; Ando M; Araki Y; Higashi T; Shoji B; Takaki A; Iwasaki Y; Sakaguchi K; Shiratori Y; Yamamoto K
J Gastroenterol Hepatol; 2008 May; 23(5):794-803. PubMed ID: 18086120
[TBL] [Abstract][Full Text] [Related]
2. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
3. Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment.
Joo MK; Yeon JE; Kim JH; Jung YK; Lee SJ; Kim JH; Yim HJ; Byun KS; Park JJ; Kim JS; Bak YT
Scand J Gastroenterol; 2008; 43(12):1514-21. PubMed ID: 18663665
[TBL] [Abstract][Full Text] [Related]
4. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
Sponseller CA; Bacon BR; Di Bisceglie AM
Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
[TBL] [Abstract][Full Text] [Related]
5. A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection.
Sharma YR; Miah AR; Saha SK; Mohammed S; Rahman M; Roy PK; Hasan M
Nepal Med Coll J; 2004 Dec; 6(2):106-11. PubMed ID: 16295739
[TBL] [Abstract][Full Text] [Related]
6. [Clinical outcome in cases of viral breakthrough during lamivudine therapy in chronic hepatitis B patients].
Ahn SH; Chang YJ; Oh SN; Choi DW; Baek SJ; Jeong WS; Choi CW; Kim KO; Yim HJ; Jo NY; Bak JJ; Kim JS; Bak YT; Lee MS; Yeon JE; Byun KS; Lee CH
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):389-96. PubMed ID: 12506243
[TBL] [Abstract][Full Text] [Related]
7. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.
Tseng PL; Lu SN; Tung HD; Wang JH; Changchien CS; Lee CM
J Viral Hepat; 2005 Jul; 12(4):386-92. PubMed ID: 15985009
[TBL] [Abstract][Full Text] [Related]
8. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
10. Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
Cetin K; Sabahattin K; Kadir D; Ahmet D; Ziyaettin D; Selim B; Mürüvvet B; Fatih B; Güngör B; Zeynel M; Yilmaz C; Atilla O
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcv-ccxcvii. PubMed ID: 15244206
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
Wang L; Yan J; Zhang ZH; Wang JB; Du YZ; Li XY; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.
Villeneuve JP; Condreay LD; Willems B; Pomier-Layrargues G; Fenyves D; Bilodeau M; Leduc R; Peltekian K; Wong F; Margulies M; Heathcote EJ
Hepatology; 2000 Jan; 31(1):207-10. PubMed ID: 10613747
[TBL] [Abstract][Full Text] [Related]
13. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
Hann HW; Fontana RJ; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Gardner SD; Brown N; Griffiths D;
Liver Transpl; 2003 Jan; 9(1):49-56. PubMed ID: 12514773
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance.
Hui JM; George J; Liddle C; Lin R; Samarasinghe D; Crewe E; Farrell GC
Am J Gastroenterol; 2002 Apr; 97(4):1003-9. PubMed ID: 12003380
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].
Kim SS; Chung MG; Ju KT; Park DK; Kwon OS; Koo YS; Kim YK; Choi DJ; Hwang YJ; Kim JH
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):405-17. PubMed ID: 12506245
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
Zhang FK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
[TBL] [Abstract][Full Text] [Related]
17. [One year treatment with lamivudine in different hepatitis B virus related hepatic diseases].
Buti M; Cotrina M; Cruz de Castro E; Jardí R; Rodríguez F; Esteban R; Guardia J
Gastroenterol Hepatol; 1999 Mar; 22(3):117-21. PubMed ID: 10228320
[TBL] [Abstract][Full Text] [Related]
18. Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.
Nikolaidis N; Vassiliadis T; Giouleme O; Tziomalos K; Grammatikos N; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis N
Clin Transplant; 2005 Jun; 19(3):321-6. PubMed ID: 15877792
[TBL] [Abstract][Full Text] [Related]
19. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
[TBL] [Abstract][Full Text] [Related]
20. HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.
Di Marco V; Di Stefano R; Ferraro D; Almasio PL; Bonura C; Giglio M; Parisi P; Cappello M; Alaimo G; Craxì A
Antivir Ther; 2005; 10(3):431-9. PubMed ID: 15918334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]